A commentry of brain tumors associated with Li-Fraumeni syndrome, followed by a case report of the development of a rare gliosarcoma in a Li-Fraumeni patient
Browsing: Disease Area > Rare tumors
Researchers have identified previously ignored mutations that, despite being rare, are likely associated with cancer growth. The discovery may lead to the development of new targeted therapies.
Lydia Makaroff of the European Cancer Patient Coalition (ECPC, Brussels, Belgium) speaks with Oncology Central about the goals and upcoming projects for the ECPC in 2017.
This review article from Future Oncology summarizes the efficacy of the latest therapeutic agents available for the treatment of patients with relapsed multiple myeloma.
This case report details a rare example of a woman with metastatic and rapidly progressive secretory paraganglioma who responded rapidly and durably to lenvatinib.
Researchers have identified a novel potential therapeutic target for an aggressive form of pediatric glioma.
To mark Rare Disease Day, Oncology Central brings you an exclusive opinion piece written by two of the principal investigators of a pivotal immunotherapy clinical trial designed specifically for rare cancer patients.
Researchers have demonstrated that IL-6 controls resistance to radiation in oral squamous cell carcinoma.